| Literature DB >> 30479465 |
Garett Dunsmore1, Petya Koleva2, Reed Taylor Sutton3, Lindsy Ambrosio3, Vivian Huang4, Shokrollah Elahi5.
Abstract
AIM: To understand the effects of delivery mode on the immune cells frequency and function in cord blood and placenta.Entities:
Keywords: CD71+ erythroid cells; Caesarian section; Cord blood; Immunophenotyping; Placental tissues; Twins; Vaginal delivery
Mesh:
Substances:
Year: 2018 PMID: 30479465 PMCID: PMC6235805 DOI: 10.3748/wjg.v24.i42.4787
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
The mother’s clinical history during pregnancy
| 34 | Ulcerative colitis | E3 pancolitis | Sulfasalazine (2 g) | 176.41 μg/mL | 11.5 | 1 | Yes |
| Omeprazole (20 mg) | |||||||
| Prenatal vitamin (1) |
FCP: Fecal calprotectin; CRP: C reaction protein.
Twins clinical data
| Gestational age (wk) | 37 | 37 |
| Sex of the baby | Female | Male |
| Birthweight (g) | 2720 | 3150 |
| APGAR Score | 9, 9, 9, 9 | 1, 8, 9 |
| FCP (12 wk of age) | 40.89 | 982 |
C-section: Caesarean section; FCP: Fecal calprotectin.
Figure 1Immunophenotyping of cord blood cells. A: Showing flow cytometry gating strategy for different immune cells in cord blood. B: Representative dot plots showing T cells (CD3, CD4 and CD8), monocytes (CD14 and CD16) and NK cells (CD56 and CD16) in cord blood of vaginally or C-section delivered newborns. C: Cumulative data showing percentages of different immune cells in cord blood. D: Representative dot plots showing expression of PD-1/LAG-3 and PD-1/TIM-3 on CD4+ T cells. E: Percentages of PD-1, LAG-3 and TIM-3 on CD4+ T cells from cord blood of twins. F: Representative dot plots showing expression of PD-1/LAG-3 and PD-1/TIM-3 on CD8+ T cells. G: Percentages of PD-1, LAG-3 and TIM-3 on CD8+ T cells from cord blood of twins. H: Representative dot plots showing percentages of CD71+CD235+ cells in cord blood of vaginally vs C-section delivered twins. I: qPCR data showing fold gene expression for TGF-β, NOX2, arginase-2, VISTA and VEGFα in enriched CD71+ erythroid cells from cord blood. NK: Natural killer; C-section: Caesarean section; PD-1: Program death-1; LAG-3: Lymphocyte-activation gene 3; TIM-3: T-cell immunoglobulin and mucin-domain containing-3; qPCR: Quantitative polymerase chain reaction; TGF-β: Transforming growth factor beta; NOX-2: The phagocyte NADPH oxidase; VISTA: V-domain Ig suppressor of T cell activation; VEGFα: Vascular endothelial growth factor A.
Figure 2Immunophenotyping of placental cells. A: Showing flow cytometry gating strategy for different immune cells in placenta. B: Representative dot plots showing T cells (CD3, CD4 and CD8), monocytes (CD14 and CD16) and NK cells (CD56 and CD16) in placenta of vaginally or C-section delivered newborns. C: Cumulative data showing percentages of different immune cells in placenta. D: Representative dot plots showing expression of PD-1/LAG-3 and PD-1/TIM-3 on CD4+ T cells. E: Percentages of PD-1, LAG-3 and TIM-3 on CD4+ T cells from placental tissues of twins. F: Representative dot plots showing expression of PD-1/LAG-3 and PD-1/TIM-3 on CD8+ T cells. G: Percentages of PD-1, LAG-3 and TIM-3 on CD8+ T cells from placental tissues of twins. H: Representative dot plots showing percentages of CD71+CD235+ cells in placental tissues of vaginally vs C-section delivered twins. I: Data showing levels of FCP in fecal samples of twins as measured by ELISA. NK: Natural killer; C-section: Caesarean section; PD-1: Program death-1; LAG-3: Lymphocyte-activation gene 3; TIM-3: T-cell immunoglobulin and mucin-domain containing-3; FCP: Fecal calprotectin; ELISA: Enzyme-linked immuno sorbent assay.